Clinical Trial Update: An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial sponsored by Emory University evaluating the investigational imaging agent 18F-rhPSMA-7.3 with mpMRI for targeted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-rhPSMA-7.3 (rhPSMA-7.3 radiotracer)

Snippet

Sponsor: Emory University | Conditions: Prostate Carcinoma | Phase 2 | Status: RECRUITING